Eric Chou1, Richard D Boyce1, Baran Balkan2, Vignesh Subbian2, Andrew Romero3, Philip D Hansten4, John R Horn4, Sheila Gephart5, Daniel C Malone6. 1. Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. 2. College of Engineering, University of Arizona, Tucson, Arizona, USA. 3. Banner University Medical Center, Tucson, Arizona, USA. 4. Department of Pharmacy, University of Washington, Seattle, Washington, USA. 5. College of Nursing, University of Arizona, Tucson, Arizona, USA. 6. Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA.
Abstract
OBJECTIVE: Alert fatigue is a common issue with off-the-shelf clinical decision support. Most warnings for drug-drug interactions (DDIs) are overridden or ignored, likely because they lack relevance to the patient's clinical situation. Existing alerting systems for DDIs are often simplistic in nature or do not take the specific patient context into consideration, leading to overly sensitive alerts. The objective of this study is to develop, validate, and test DDI alert algorithms that take advantage of patient context available in electronic health records (EHRs) data. METHODS: Data on the rate at which DDI alerts were triggered but for which no action was taken over a 3-month period (override rates) from a single tertiary care facility were used to identify DDIs that were considered a high-priority for contextualized alerting. A panel of DDI experts developed algorithms that incorporate drug and patient characteristics that affect the relevance of such warnings. The algorithms were then implemented as computable artifacts, validated using a synthetic health records data, and tested over retrospective data from a single urban hospital. RESULTS: Algorithms and computable knowledge artifacts were developed and validated for a total of 8 high priority DDIs. Testing on retrospective real-world data showed the potential for the algorithms to reduce alerts that interrupt clinician workflow by more than 50%. Two algorithms (citalopram/QT interval prolonging agents, and fluconazole/opioid) showed potential to filter nearly all interruptive alerts for these combinations. CONCLUSION: The 8 DDI algorithms are a step toward addressing a critical need for DDI alerts that are more specific to patient context than current commercial alerting systems. Data commonly available in EHRs can improve DDI alert specificity.
OBJECTIVE: Alert fatigue is a common issue with off-the-shelf clinical decision support. Most warnings for drug-drug interactions (DDIs) are overridden or ignored, likely because they lack relevance to the patient's clinical situation. Existing alerting systems for DDIs are often simplistic in nature or do not take the specific patient context into consideration, leading to overly sensitive alerts. The objective of this study is to develop, validate, and test DDI alert algorithms that take advantage of patient context available in electronic health records (EHRs) data. METHODS: Data on the rate at which DDI alerts were triggered but for which no action was taken over a 3-month period (override rates) from a single tertiary care facility were used to identify DDIs that were considered a high-priority for contextualized alerting. A panel of DDI experts developed algorithms that incorporate drug and patient characteristics that affect the relevance of such warnings. The algorithms were then implemented as computable artifacts, validated using a synthetic health records data, and tested over retrospective data from a single urban hospital. RESULTS: Algorithms and computable knowledge artifacts were developed and validated for a total of 8 high priority DDIs. Testing on retrospective real-world data showed the potential for the algorithms to reduce alerts that interrupt clinician workflow by more than 50%. Two algorithms (citalopram/QT interval prolonging agents, and fluconazole/opioid) showed potential to filter nearly all interruptive alerts for these combinations. CONCLUSION: The 8 DDI algorithms are a step toward addressing a critical need for DDI alerts that are more specific to patient context than current commercial alerting systems. Data commonly available in EHRs can improve DDI alert specificity.
Authors: Amy J Grizzle; Maysaa H Mahmood; Yu Ko; John E Murphy; Edward P Armstrong; Grant H Skrepnek; William N Jones; Gregory P Schepers; W Paul Nichol; Antoun Houranieh; Donna C Dare; Christopher T Hoey; Daniel C Malone Journal: Am J Manag Care Date: 2007-10 Impact factor: 2.229
Authors: David N Juurlink; Muhammad Mamdani; Alexander Kopp; Andreas Laupacis; Donald A Redelmeier Journal: JAMA Date: 2003-04-02 Impact factor: 56.272
Authors: Hanna M Seidling; Ulrike Klein; Matthias Schaier; David Czock; Dirk Theile; Markus G Pruszydlo; Jens Kaltschmidt; Gerd Mikus; Walter E Haefeli Journal: Int J Med Inform Date: 2014-01-13 Impact factor: 4.046
Authors: Adam Wright; Dustin S McEvoy; Skye Aaron; Allison B McCoy; Mary G Amato; Hyun Kim; Angela Ai; James J Cimino; Bimal R Desai; Robert El-Kareh; William Galanter; Christopher A Longhurst; Sameer Malhotra; Ryan P Radecki; Lipika Samal; Richard Schreiber; Eric Shelov; Anwar Mohammad Sirajuddin; Dean F Sittig Journal: J Am Med Inform Assoc Date: 2019-10-01 Impact factor: 4.497
Authors: Martin Jung; Daniel Riedmann; Werner O Hackl; Alexander Hoerbst; Monique W Jaspers; Laurie Ferret; Kitta Lawton; Elske Ammenwerth Journal: BMC Med Inform Decis Mak Date: 2012-10-02 Impact factor: 2.796
Authors: Thomas Reese; Adam Wright; Siru Liu; Richard Boyce; Andrew Romero; Guilherme Del Fiol; Kensaku Kawamoto; Daniel Malone Journal: Am J Health Syst Pharm Date: 2022-06-23 Impact factor: 2.980
Authors: Greet Van De Sijpe; Charlotte Quintens; Karolien Walgraeve; Eva Van Laer; Jens Penny; Greet De Vlieger; Rik Schrijvers; Paul De Munter; Veerle Foulon; Minne Casteels; Lorenz Van der Linden; Isabel Spriet Journal: BMC Med Inform Decis Mak Date: 2022-02-22 Impact factor: 2.796
Authors: Arthur T M Wasylewicz; Britt W M van de Burgt; Thomas Manten; Marieke Kerskes; Wilma N Compagner; Erik H M Korsten; Toine C G Egberts; Rene J E Grouls Journal: Clin Pharmacol Ther Date: 2022-06-27 Impact factor: 6.903